PROCEPT BioRobotics (PRCT) Invested Capital (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Invested Capital for 7 consecutive years, with $391.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital fell 10.41% year-over-year to $391.8 million in Q2 2026; TTM through Jun 2026 was $391.8 million, a 10.41% decrease from a year earlier, with the FY2025 full-year figure at $417.5 million, down 8.38% from the prior year.
• Invested Capital was $391.8 million for Q2 2026 at PROCEPT BioRobotics, down from $399.3 million in the prior quarter.
• Over five years, Invested Capital peaked at $455.7 million in Q4 2024 and troughed at $207.2 million in Q2 2023.
• A 5-year average of $340.1 million and a median of $325.7 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital decreased 28.48% in 2023 and surged 47.28% in 2024, its largest moves.
• Over 5 years, Invested Capital stood at $248.3 million in 2022, then jumped by 34.51% to $334.0 million in 2023, then soared by 36.44% to $455.7 million in 2024, then retreated by 8.38% to $417.5 million in 2025, then decreased by 6.16% to $391.8 million in 2026.
• The last three Invested Capital figures came in at $391.8 million (Q2 2026), $399.3 million (Q1 2026), and $417.5 million (Q4 2025), per Business Quant data.